EY's 20th Pulse of the MedTech Industry report finds the global medical technology industry at a turning point, with record financing and dealmaking but growth concentrated among a few leaders. MedTech revenue reached about $650 billion in 2025, up 11%. In the first half of 2026 it hit $325 billion, up 7.1% year on year. Financing hit a record $63 billion in the year to June 30, 2026, up 87%. Initial public offerings and debt made up about 80% of it. M&A value reached roughly $130 billion, the highest in over a decade, driven by a few blockbuster deals. First-half 2026 deal value rose 160% against the same period in 2025. "The broader sector players are at a turning point where discipline is essential to convert innovation into profitable growth," said John Babitt, EY Global MedTech Leader.

EY added nearly 10,000 staff globally in its 2026 financial year as AI-related revenue surged almost 50%. The Big Four firm's workforce reached 415,000, with most growth concentrated in global delivery services and offshoring centres. The Americas division saw headcount decrease by roughly 4,500, or 5%. Overall global revenue rose 4.7% to $57 billion. EY-Parthenon was the fastest-growing service line, with revenue increasing 7.4% to $6.8 billion, marking a turnaround after two years of minimal growth. Tax revenue rose 6% to $13.8 billion, whilst consulting grew 4.4% to $17.4 billion. The results reflect EY's "All-In" strategy under global chair Janet Truncale, with billions invested in transforming operations and AI services.

An Ernst & Young study found US oil and gas producers reached record production in 2025 while becoming more selective with investments. The analysis of 30 major exploration and production companies, representing 43% of US oil and gas output, showed oil production hit a study-period high, yet reserve additions from extensions and discoveries declined 11% year over year and failed to fully replace production volumes for the first time since 2021. Total capital expenditures fell 49% year over year, whilst M&A spending declined 70%. Exploration spending dropped 11% to $4.8 billion, representing only 3% of total capital expenditures. Natural gas showed stronger fundamentals, with production rising 18%, reserves increasing 14%, and discoveries up 21%.